At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Chatbot Interventiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Automated Symptom Tracking for Measurement-Based Care of Depression
In Brief
A clinical study evaluating Chatbot Intervention for Depression, Postpartum and Depression, Unipolar. Completed, enrolled 31 participants across 2 sites.
Detailed Summary
The goal of this research is to bridge a significant "effectiveness" gap in the treatment of depression. The investigators have developed a chatbot which will assist in performing measurement-based care (MBC) via Facebook Messenger. Participants will be randomized to either Usual Care or Usual Care with additional Chatbot Care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Postpartum, Depression, Unipolar
CountriesUnited States
CollaboratorsEndeavor Health
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartFeb 2019
First PostedJun 2019
Primary CompletionFeb 2020
TodayJul 2026
First PostedJun 19, 2019
Enrollment StartFeb 20, 2019
Primary CompletionFeb 29, 2020
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 7.0 years ago
Interventions
Chatbot Interventiondevice
a chatbot will be used to monitor depression severity